Phase I trial of erlotinib (E), modified FOLFOX6 (mFOLFOX6), and bevacizumab (B) as first-line therapy for metastatic colorectal cancer (MCRC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 15076-15076
Author(s):  
D. Singh ◽  
L. Rath ◽  
J. A. Bokar ◽  
J. M. Brell ◽  
M. M. Cooney ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
Phase I Trial ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Modified Folfox6

scholarly journals Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer

2008 ◽  
Vol 98 (6) ◽  
pp. 1034-1038 ◽  
Author(s):  
Y Yamada ◽  
M Tahara ◽  
T Miya ◽  
T Satoh ◽  
K Shirao ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer

2018 ◽  
Vol 9 (22) ◽  
pp. 4092-4098
Author(s):  
Shigeyoshi Iwamoto ◽  
Hiromichi Maeda ◽  
Shoichi Hazama ◽  
Koji Oba ◽  
Naoko Okayama ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Wild Type ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer

2002 ◽  
Vol 50 (5) ◽  
pp. 383-391 ◽  
Author(s):  
Ychou M. ◽  
Raoul J. ◽  
Desseigne F. ◽  
Borel C. ◽  
Caroli-Bosc F. ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Single Agent ◽  
High Dose ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document